Ignite Creation Date:
2024-07-17 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466057
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-13
Brief Title:
Metacognitive Therapy for Obsessive-Compulsive Disorder
Sponsor:
Northeast Normal University
Organization:
Northeast Normal University
Study Overview
Official Title:
The Efficacy of Metacognitive Therapy for Obsessive-compulsive Disorder
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MCTOCD
Brief Summary:
The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder OCD The main questions it aims to answer are
Can metacognitive therapy significantly reduce participants levels of obsessive-compulsive symptoms Can metacognitive therapy significantly improve participants metacognitive adaptations
The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD
Participants will
Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks
Be assessed for symptoms and metacognitive beliefs at pre-intervention post-intervention and 12 weeks post-intervention
Can metacognitive therapy significantly reduce participants levels of obsessive-compulsive symptoms Can metacognitive therapy significantly improve participants metacognitive adaptations
The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD
Participants will
Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks
Be assessed for symptoms and metacognitive beliefs at pre-intervention post-intervention and 12 weeks post-intervention
Detailed Description:
This study will be a randomised controlled clinical trial Participants who meet the enrolment criteria will be randomised into an experimental group and a control group Participants in the experimental group will receive 8-15 weeks of metacognitive therapy while participants in the control group will receive the same amount of time of regular treatment without psychotherapy components
The researchers will assess participants obsessive-compulsive symptoms and metacognitive levels before after and 12 weeks after the intervention Assessment measures will be the Yale Brown Obsessive-Compulsive Scale Y-BOCS and the Metacognition Questionnaire MCQ-30
By comparing the assessment results of the two groups of participants conclusions will be drawn as to whether metacognitive therapy can have a positive effect on a Chinese OCD sample
The researchers will assess participants obsessive-compulsive symptoms and metacognitive levels before after and 12 weeks after the intervention Assessment measures will be the Yale Brown Obsessive-Compulsive Scale Y-BOCS and the Metacognition Questionnaire MCQ-30
By comparing the assessment results of the two groups of participants conclusions will be drawn as to whether metacognitive therapy can have a positive effect on a Chinese OCD sample
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None